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Abstract 
Sarcomatoid carcinoma is an extremely rare
biphasic tumor characterized by a combination
of malignant epithelial and mesenchymal cells.
Limited  data  on  sarcomatoid  carcinoma
showed  that  most  cases  occurred  with
advanced  local  disease  and  metastasis,  and
paraneoplastic syndromes were rare. We pre  -
sent the case of a 63-year-old man with lung
sarcomatoid  carcinoma  associated  with
jejunum metastasis and leukocytosis, and its
clinical,  macroscopic,  and  histopathological
features.  This  case  emphasizes  the  import  -
ance of recognizing paraneoplastic syndromes
and metastasis of sarcomatoid carcinoma at
diagnosis. 
Introduction
Sarcomatoid  carcinoma  is  an  extremely
rare biphasic tumor that is characterized by a
combination of malignant epithelial and mes-
enchymal  cells.
1-4 Although  sarcomatoid
carcin  oma has been reported in many sites of
the body such as the bladder, colon, uterus,
ovary, breast, and lung, few pathologists have
the opportunity to study very many of them. As
for lung cancer, sarcomatoid carcinoma has
also  been  described  by  a  variety  of  names
including  spindle  cell  carcinoma,  giant  cell
carcinoma,  carcinosarcoma,  blastoma,  and
others. Fishback et al. designated sarcomatoid
carcinomas  as  pleomorphic  (spindle/giant
cell)  carcinomas  of  the  lung  because  both
spindle and giant cell components often are
found in the same tumors.
4 The World Health
Organization  (WHO)  histological  classifica-
tion of lung tumors or carcinomas with pleo-
morphic,  sarcomatoid,  or  sarcomatous  ele-
ments includes: 1) carcinomas with spindle
and/or  giant  cells  (pleomorphic  carcinoma,
spindle cell carcinoma, and giant cell carcin  -
oma), 2) carcinosarcoma, 3) pulmonary blast-
oma, and 4) others. Spindle and giant cell car-
cinoma  and  carcinosarcoma  comprise  only
0.4%  and  0.1%  of  all  lung  malignancies,
respectively.
3
There  is  no  specific  clinical  presentation
and  typical  symptoms  include  chest  pain,
cough, hemoptysis, dyspnea, fever, and weight
loss.
5,6 Limited data on sarcomatoid carcinoma
showed that most cases were associated with
advanced local disease at diagnosis. However,
metastasis and paraneoplastic syndromes are
rarely seen in the clinic. We present the case of
a  63-year-old  man  with  lung  sarcomatoid
carcin  oma with jejunal metastasis and leuko-
cytosis, as well as its clinical, macroscopic, and
histopathological features. 
Case Report
A 63-year-old man was admitted to the hos-
pital  because  of  a  diagnosis  of  lung  cancer
after a surgical excision of a lung tumor. The
patient had been in stable health without any
symptoms before a regular health examination
two months earlier. A chest X-ray examination
showed a mass in the right pulmonary lobe. A
computed  tomography  (CT)  scan  showed  a
lesion about 45 mm in diameter in the inferior
lobe of the right lung with breaching of the
pleurae (Figure 1). Ultrasonographic examin  -
ation of the abdomen showed swollen lymph
nodes,  the  largest  one  of  which  was  32¥21
mm. A video-assistant thoracoscope was con-
ducted  and  a  biopsy  was  performed.  Frozen
pathological sections showed poorly differenti-
ated  squamous  cell  carcinoma.  The  inferior
lobe of the right lung and mediastinal lymph
nodes were removed surgically. The resection
pathological  diagnosis  was  polymorph  sarco-
matoid  carcinoma  with  invasion  of  the 
pleurae. Mediastinal lymph nodes were nega-
tive. A CT scan of the thorax in the supine
position without the administration of contrast
material revealed a large well-defined soft-tis-
sue mass measuring 5¥4¥4 cm in the right
lung  lobe  with  breaching  of  the  pleura.
Abdominal ultrasonography revealed a well-cir-
cumscribed  mass  of  10.4¥9.9¥5.4  cm  with
enlarged lymph nodes, the largest one of which
was 19¥12 mm. A FDG-PET/CT scan with atten-
uation  revealed  a  well-demarcated  elliptical
mass  in  the  abdomen  with  dimensions  of
10¥9¥5 cm and extensive 
18FDG uptake. 
The patient recovered and came to this hos-
pital for further treatment. On physical exam -
ination, he appeared healthy with a body tem-
perature  of  36.2°C.  The  lungs,  heart,  and
abdomen  were  normal.  Laboratory  studies
showed normal liver and renal function. The
urine  and  dejecta  were  negative.  The  pro-
thrombin  and  partial-thromboplastin  times
were  normal.  The  red-cell  count  was
2.95¥10
12/L and the hypochromia was 89 g/L.
The  white-cell  count  was  25.42¥10
9/L,  with
88.4%  neutrophils,  6.3%  lymphocytes,  2.6%
monocytes,  and  the  platelet  count  was
268¥10
9/L.  An  abdominal  ultrasonographic
examination  revealed  a  well-circumscribed
mass of 10.4¥9.9¥5.4 cm with relatively lower
echogenicity  but  high  central  echogenicity,
which  was  likely  an  intestinal  structure.
Lymph nodes were swollen and the largest one
was 19¥12 mm (Figure 1). A FDG-PET/CT scan
with  attenuation  showed  a  significantly
increased tracer uptake in the metastatic mass
of  the  small  intestine,  the  seventh  thoracic
vertebra, and the sacrum. (Figure 1).
After communication with the patient, and
according to his wishes, a second resection of
the  abdominal  mass  was  performed.  The
tumor, well coated with membrane, was locat-
ed at the star part of the jejunum, 3 cm from
the transverse mesocolon, encroaching on the
mesentery (Figure 2). The whole lesion, with
part of the jejunum, was removed. The patho-
logical diagnosis was sarcomatoid carcinoma.
The  immunohistochemical  staining  results
showed that it was positive for epithelial mem-
brane antigen (EMA), cytokeratin (CK), S-100,
vimentin, and TTF-1; CK7 was focally positive;
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(Figure  3).  Surgical  removal  and  immuno  -
histochemical staining of the lung lesion were
also done and the results showed that it was
positive for CK and vimentin, and focally posi-
tive for EMA; but negative for CK7, CD20, and
desmin (Figure 3).
After surgery, our patient received one cycle
of chemotherapy with a regimen of docetaxel
and cisplatin. He showed no response to the
drugs and a CT scan reported new lesions in
the pleurae and diaphragm. Considering the
expected poor prognosis owing to disseminat-
ed disease, the patient declined further treat-
ment. 
Discussion 
Sarcomatoid carcinoma of the lung is a rare
histological subtype and has been reported as
having a relatively poorer prognosis.
1,5-9It is dif-
ficult to distinguish sarcomatoid carcinomas
from true sarcomas, such as malignant fibrous
histiocytoma and fibrosarcoma, if no carcin  -
omatous areas are recognized on the hema-
toxylin-and-eosin  stained  sections.  Immuno  -
cytochemistry seems to be the gold standard
for  diagnosis  of  sarcomatoid  carcinoma,
because CT, MR, and PET scans appear to be
less efficient, and standard light microscopy is
not always adequate. However, carcinoembry-
onic  antigen,  EMA,  CK,  pancreatin,  chromo-
granin A, CD56, and synaptophysin are highly
specific markers for the carcinomatous compo-
nents,  while  desmin,  vimentin,  and  smooth
muscle/sarcomeric actin show an affinity for
the sarcomatous elements.
7,9,10
With respect to the histogenesis of sarcoma-
toid carcinoma, some authors have suggested
that sarcomatoid carcinoma is derived from a
single totipotent stem cell that has the ability
to pursue both epithelial and mesenchymal dif-
ferentiation.
1,2,4 Halachmi  et  al. analyzed  the
loss of heterozygosity (LOH) in both the car  -
cinomatous  and  sarcomatous  components  of
six bladder tumors by microsatellite analysis of
40 markers from 19 human chromosomes. The
results showed that all six cases revealed iden-
tical LOH on chromosomal arms 9p, 9q, 8p, and
8q, corresponding to relatively early events in
bladder carcinogenesis.
11 Armstrong et al. ana-
lyzed the TP53 mutation status of a series of 17
sarcomatoid urothelial carcinomas using sin-
gle-strand  conformation  polymorphism,  DNA
sequencing,  and  p53  immunohistochemistry.
The results showed that both the sarcomatoid
and  epithelial  tumor  components  in  all  17
cases  demonstrated  concordant  p53  expres-
sion patterns and five carcinomas were with
identical  TP53  point  mutations  in  both  the
epithelial  and  sarcomatoid  components.
12
These results suggest that despite their con-
Article
Figure 1. Computed tomography scan of the right lung lesion; ultrasonic and PET images
of the intestinal lesion.
Figure 2. View of the surgery (A) and the lesion that was removed surgically (B). The
tumor was located at the star part of the jejunum, 3 cm from the transverse mesocolon,
encroaching on the mesentery.
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the sarcomatoid and carcinomatoid elements
of this uncommon tumor might share a com-
mon clonal origin or be derived from a com-
mon stem cell.
The typical symptoms of pulmonary sarco-
matoid carcinoma are the same as for most
lung cancers and include chest pain, cough,
hemoptysis, dyspnea, fever, and weight loss.
Paraneoplastic  syndromes  such  as  dermato-
myositis  and  Trousseau’s  syndrome  were
reported  in  uterine  sarcomatoid  carcinoma
and  ovarian  carcinosarcoma.
13-15 However,  no
paraneoplastic  syndromes  were  reported  in
lung  sarcomatoid  carcinoma  although  they
occurred with about 15-20% of small cell lung
cancers and 5-8% of non-small cell lung can-
cers.
16
The most common metastases to invade the
small intestine are of gastrointestinal or gyne-
cological origin, such as those arising from the
colon, uterine cervix, or ovaries.
17 Small intes-
tinal metastases from extra-abdominal malig-
nancies have been reported previously, mainly
in cases of melanoma
18 and lung cancer.
17,19,20
Berger et al.
20 reported that only six of 1399
(0.5%)  patients  with  primary  lung  cancer
developed clinically apparent small intestinal
metastases, and McNeill et al.
17 found a lower
frequency of six among 6006 hospital admis-
sions for lung cancer. In lung cancer patients,
all  cell  types  may  develop  small  intestinal
metastases.
17,20,21 It was reported that large cell
and small cell carcinoma lead to gastrointes  -
tinal metastases more often than other histo-
logical types.
21,22 This is the first documented
case of lung sarcomatoid carcinoma invading
the small intestine and accompanied by leuko-
cytosis. The morphology of sarcomatoid carci-
noma cells from both lung and jejunal lesions
was  similar  and  the  immunohistochemical
stains for CK, EMA, and vimentin were positive
while  that  for  CD20  was  negative.
Furthermore, TTF-1 was positive and CK7 was
focally  positive  in  the  jejunal  lesion,  which
supports  the  diagnosis  of  a  lung  derivation.
Rossi et al.
23 reported that in 18 lung cancers
with intestinal metastasis (10 large-cell undif-
ferentiated carcinomas and eight adenocarcin  -
omas),  all  cases  were  stained  positively  for
CK7  and  89%  for  TTF-1,  whereas  CK20  and
CDX2 were completely negative. They suggest-
ed  that  as  for  the  differential  diagnosis,
immunohistochemical  staining  with  TTF-1,
CDX2, CK7, and CK20 is helpful in highlight-
ing the lung primary. 
In conclusion, sarcomatoid carcinoma of the
lung is a rare tumor with a high malignant
potential, and might derive from a stem cell. At
present, no clinical tests are available for its
early diagnosis. Attention should be pay to the
importance of paraneoplastic syndromes and
metastasis at diagnosis. The possibilities for
therapy  are  confined  to  radical  resection,
although novel effective treatment was expect-
ed in the clinic. 
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magnification. Tumor cells were negative for CD117 (D), CDX2 (E), and CD20 (H).
Cytokeratin (F), epithelia/membrane antigen (I), S-100 (J), TTF-1 (K), and vimentin (L)
were positive. Cytokeratin 7 (G) was focally positive. 








B[Rare Tumors 2010; 2:e44] [page 123]
1999;50:515-8. 
16. Hansen M. Paraneoplastic syndromes and
tumor markers for small cell and non-small
cell  lung  cancer.  Curr  Opin  Oncol  1990;
2:345-51. 
17. McNeill PM, Wagman LD, Neifeld JP. Small
bowel metastases from primary carcinoma
of the lung. Cancer 1987;59:1486-9. 
18. Agrawal S, Yao TJ, Coit DG. Surgery for
melanoma metastatic to the gastrointes  -
tinal tract. Ann Surg Oncol 1999;6:336-44.
19. Stenbygaard LE, Sorensen JB. Small bowel
metastases in non-small cell lung cancer.
Lung cancer 1999;26:95-101. 
20. Berger A, Cellier C, Daniel C, et al. Small
bowel metastases from primary carcinoma
of the lung: clinical findings and outcome.
Am J Gastroenterology 1999;94:1884-7. 
21. Antler AS, Ough Y, Pitchumoni CS, et al.
Gastrointestinal  metastasis  from  malig-
nant  tumors  of  the  lung.  Cancer  1982;
49:170-2. 
22. Kanemoto K, Kurishima K, Ishikawa H, et
al. Small intestinal metastasis from small
cell lung cancer. Intern Med 2006;45:967-70.
23. Rossi G, Marchioni A, Romagnani E, et al.
Primary lung cancer presenting with gas-
trointestinal  tract  involvement:  clinico-
pathologic and immunohistochemical fea-
tures in a series of 18 consecutive cases. J
Thorac Oncol 2007;2:115-20. 
Article